IRIS
CIFALDI, LOREDANA CONCETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.328
EU - Europa 330
AS - Asia 35
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 1.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.326
IE - Irlanda 140
IT - Italia 121
GB - Regno Unito 16
CN - Cina 15
KR - Corea 13
SE - Svezia 12
DE - Germania 10
MK - Macedonia 7
FR - Francia 5
RU - Federazione Russa 4
UA - Ucraina 3
A1 - Anonimo 2
BE - Belgio 2
FI - Finlandia 2
JP - Giappone 2
MY - Malesia 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
AR - Argentina 1
BZ - Belize 1
CA - Canada 1
CZ - Repubblica Ceca 1
EU - Europa 1
IN - India 1
IR - Iran 1
NL - Olanda 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.697
Salva come PNG Salva come JPEG
Città #
Chandler 185
Fairfield 153
Dublin 128
Ann Arbor 125
Wilmington 110
Houston 104
Medford 85
Ashburn 71
Woodbridge 69
Seattle 68
Rome 59
Cambridge 52
Lawrence 42
New York 21
San Diego 21
Seoul 13
Engelhard 12
London 9
Nepi 9
Colorado Springs 8
Brooklyn 7
Milan 7
Salt Lake City 5
Del Norte 4
Falls Church 4
Redmond 4
Buffalo 3
Cedarhurst 3
Council Bluffs 3
Kilburn 3
North Hollywood 3
Norwalk 3
Skopje 3
Beijing 2
Brussels 2
Center 2
Chengdu 2
Falkenstein 2
Genoa 2
Hounslow 2
Jiaxing 2
Lappeenranta 2
Los Angeles 2
Manitou Springs 2
Naselba Caska 2
Roebling 2
Subang Jaya 2
Torremaggiore 2
Verona 2
Xiangfan 2
Zhengzhou 2
Belgrade 1
Belize City 1
Berlin 1
Bratislava 1
Chicago 1
Deiva Marina 1
Eden Prairie 1
Frankfurt am Main 1
Garden City 1
Guangzhou 1
Guidonia Montecelio 1
Hangzhou 1
La Plata 1
Landshut 1
Las Vegas 1
Leawood 1
Ludwigshafen am Rhein 1
Mülheim 1
Nanjing 1
Naples 1
Oradea 1
Osaka 1
Palo Alto 1
Paris 1
Prescot 1
Pune 1
Quanzhou 1
Redwood City 1
San Francisco 1
San Jose 1
Sant'Ambrogio di Valpolicella 1
Singapore 1
St. George 1
Taizhou 1
Tirana 1
Toronto 1
Waltham 1
Totale 1.469
Salva come PNG Salva come JPEG
Nome #
DNAM-1 Activating Receptor and Its Ligands: How Do Viruses Affect the NK Cell-Mediated Immune Surveillance during the Various Phases of Infection? 158
Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies. 111
Polyphenols affect the humoral response in cancer, infectious and allergic diseases and autoimmunity by modulating the activity of TH1 and TH2 cells 87
Nutlin-3a Enhances Natural Killer Cell-Mediated Killing of Neuroblastoma by Restoring p53-Dependent Expression of Ligands for NKG2D and DNAM-1 Receptors 70
Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma 62
PlGF Immunological Impact during Pregnancy 53
IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma 52
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma 51
The {BET}-bromodomain inhibitor {JQ}1 renders neuroblastoma cells more resistant to {NK} cell-mediated recognition and killing by downregulating ligands for {NKG}2D and {DNAM}1 receptors 50
GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγovercomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape 46
The immune system view of the coronavirus SARS-CoV-2 44
CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses 44
ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis 43
Identification of a Genetic Variation in ERAP1 Aminopeptidase that Prevents Human Cytomegalovirus miR-UL112-5p-Mediated Immunoevasion 42
Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration 41
Editorial: Molecular Strategies Aimed to Boost NK Cell-Based Immunotherapy of Cancer 41
Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM 40
NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells 39
Enhancement of neuroblastoma NK-cell-mediated lysis through NF-kB p65 subunit-induced expression of FAS and PVR, the loss of which is associated with poor patient outcome 39
Virological and immunological features of SARS-COV-2 infected children with distinct symptomatology 36
T and NK cells: two sides of tumor immunoevasion 35
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors 34
ERAP1 controls the interaction of the inhibitory receptor KIR3DL1 with HLA-B51:01 by affecting natural killer cell function 34
ERAAP modulation: A possible novel strategy for cancer immunotherapy? 33
HLA-E and the origin of immunogenic self HLA epitopes 33
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 31
Natural killer cells efficiently reject lymphoma silenced for the endoplasmic reticulum aminopeptidase associated with antigen processing 31
Chronic eczema in a patient with Leukocyte Adhesion Deficiency (LAD) type I 31
Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma 30
DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study. 30
Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers 29
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective 27
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma 27
Role of endoplasmic reticulum aminopeptidases in health and disease: from infection to cancer 26
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 25
IFNAR2 deficiency causing dysregulation of NK cell functions and presenting with hemophagocytic lymphohistiocytosis 25
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors 25
Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time 25
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 25
Regulation of {ERAP}1 and {ERAP}2 genes and their disfunction in human cancer 25
TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells 24
Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for {NK} Cell-Activating Receptors 24
Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect 23
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia 20
NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2 19
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma 17
Interleukin 12-activated lymphocytes influence tumor genetic programs 17
Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness 11
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 11
Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma 6
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 4
Totale 1.906
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 3 13 14 11 9 7
2020/2021728 10 6 10 35 42 4 391 66 60 24 57 23
2021/2022398 29 14 13 26 20 41 9 16 70 24 8 128
2022/2023558 47 58 32 52 43 126 56 35 46 33 18 12
2023/2024165 27 8 15 4 19 25 15 4 2 33 13 0
Totale 1.906